Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 14 (3) , 328-332
- https://doi.org/10.1097/01.ede.0000060457.51194.bc
Abstract
Although several genetic determinants (mutations or polymorphisms) have been associated with increased risk of venous thromboembolism, the overall influence of genetic factors on this disease is unknown. We linked the Danish Twin Registry, which includes twins born 1870–1953, with the Danish National Registry of Patients, comprising all hospitalizations in Denmark since 1977. We then determined the risk of venous thromboembolism as determined from discharge diagnosis. We identified 26,982 twins who were alive on 1 January 1977, and computed measures of familial and genetic association of venous thrombotic disorders. Individuals were classified according to zygosity and hospitalization with venous thromboembolism. Since 1977, 678 twins were hospitalized with an episode of venous thromboembolism. Of these, only 545 pairs (281 male pairs and 264 female pairs) were alive in 1977. For men, the concordance rates for mono- and dizygotic twin pairs, respectively, were 0.22 (95% confidence interval = 0.14 to 0.30) and 0.08 (0.04–0.12). The odds ratio (interpreted as the relative risk of venous thromboembolism for one twin, given venous thromboembolism in the partner twin) was 13.5 (7.3–24.8) among monozygotic twins and 3.8 (1.8–8.3) among dizygotic twins. The respective correlations for venous thromboembolism were 0.55 (0.38–0.70) and 0.26 (0.09–0.42). The proportion of the variance attributable to genetic effects on venous thromboembolism in males was 55% (39%–68%). The remaining variation could be attributed to men’s nonfamilial environments. In contrast, for women there was no intra–twin pair similarity for venous thromboembolism. We found differences in genetic susceptibility to venous thromboembolism between the sexes, with genetic factors playing a substantially stronger role in males than in females.Keywords
This publication has 26 references indexed in Scilit:
- Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous ThromboembolismAnnals of Internal Medicine, 1999
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- The prevalence of risk factors for venous thromboembolism among hospital patientsArchives of internal medicine (1960), 1992
- Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460Blood, 1990
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981